AU3479700A - Genes associated with diseases of the colon - Google Patents

Genes associated with diseases of the colon

Info

Publication number
AU3479700A
AU3479700A AU34797/00A AU3479700A AU3479700A AU 3479700 A AU3479700 A AU 3479700A AU 34797/00 A AU34797/00 A AU 34797/00A AU 3479700 A AU3479700 A AU 3479700A AU 3479700 A AU3479700 A AU 3479700A
Authority
AU
Australia
Prior art keywords
colon
diseases
genes associated
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34797/00A
Inventor
Tod M. Klingler
Preeti Lal
Wayne Volkmuth
Michael G. Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Publication of AU3479700A publication Critical patent/AU3479700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AU34797/00A 1999-02-22 2000-02-01 Genes associated with diseases of the colon Abandoned AU3479700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25538199A 1999-02-22 1999-02-22
US09255381 1999-02-22
PCT/US2000/002595 WO2000050588A2 (en) 1999-02-22 2000-02-01 Genes associated with diseases of the colon

Publications (1)

Publication Number Publication Date
AU3479700A true AU3479700A (en) 2000-09-14

Family

ID=22968072

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34797/00A Abandoned AU3479700A (en) 1999-02-22 2000-02-01 Genes associated with diseases of the colon

Country Status (5)

Country Link
EP (1) EP1155126A2 (en)
JP (1) JP2002536995A (en)
AU (1) AU3479700A (en)
CA (1) CA2361743A1 (en)
WO (1) WO2000050588A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002048370A2 (en) * 2000-10-31 2002-06-20 Diadexus, Inc. Compositions and methods relating to colon specific genes and proteins
WO2002077234A2 (en) * 2000-10-31 2002-10-03 Diadexus, Inc. Compositions and methods relating to colon specific genes and proteins
DE10061110B4 (en) * 2000-12-07 2006-12-21 Schaller, Gerhard, Prof. Dr. med. Expression of keratin genes 8 and 18 for the treatment of tumors, in particular breast cancer
CN101613405A (en) * 2002-06-06 2009-12-30 肿瘤疗法科学股份有限公司 Gene relevant and polypeptide with human colon carcinoma
CA2488404C (en) 2002-06-06 2012-11-27 Oncotherapy Science, Inc. Genes and polypeptides relating to human colon cancers
EP1380644A1 (en) * 2002-07-08 2004-01-14 Kylix B.V. The use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role
US20080199468A1 (en) * 2004-02-24 2008-08-21 Oncotherapy Science, Inc. Method For Diagnosing Colorectal Cancers
FR2919063B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD OF DETERMINING LEUCOCYTE ELASTASE INHIBITOR FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER.
FR2919065B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD FOR DETERMINING APOLIPOPROTEIN AI FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
FR2919064B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD OF ASSAYING APOLIPOPROTEIN ALL FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
FR2919062B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD OF DETERMINING AMINOACYLASE 1 FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER.
US9726670B2 (en) 2007-07-19 2017-08-08 Biomerieux Method for the assay of liver fatty acid binding protein, ACE and CA 19-9 for the in vitro diagnosis of colorectal cancer
FR2919060B1 (en) 2007-07-19 2012-11-30 Biomerieux Sa METHOD OF DETERMINING EZRINE FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
FR2919061B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD OF DOSING PLASTINE-I FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER.
FR2933773B1 (en) 2008-07-10 2013-02-15 Biomerieux Sa METHOD FOR DETERMINING THE ISOMERASE DISULFIDE PROTEIN FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
KR102340685B1 (en) * 2009-02-20 2021-12-17 가니메드 파마슈티칼스 게엠베하 Methods and compositions for diagnosis and treatment of cancer
EP2221063A1 (en) 2009-02-20 2010-08-25 Ganymed Pharmaceuticals AG Methods and compositions for diagnosis and treatment of cancer
EP3305813B1 (en) 2009-11-11 2020-01-15 Ganymed Pharmaceuticals GmbH Antibodies specific for claudin 6 (cldn6)
EP2404936A1 (en) 2010-07-06 2012-01-11 Ganymed Pharmaceuticals AG Cancer therapy using CLDN6 target-directed antibodies in vivo
UA127584C2 (en) 2011-05-13 2023-10-25 Астеллас Фарма Інк. ANTIBODIES FOR THE TREATMENT OF CANCER DISEASES IN WHICH CLAUDIN 6 IS EXPRESSED
WO2015014376A1 (en) 2013-07-31 2015-02-05 Biontech Ag Diagnosis and therapy of cancer involving cancer stem cells

Also Published As

Publication number Publication date
WO2000050588A3 (en) 2000-12-14
CA2361743A1 (en) 2000-08-31
EP1155126A2 (en) 2001-11-21
WO2000050588A2 (en) 2000-08-31
JP2002536995A (en) 2002-11-05

Similar Documents

Publication Publication Date Title
AU3479700A (en) Genes associated with diseases of the colon
AU3928300A (en) Genes associated with diseases of the kidney
AU2001277653A1 (en) Diagnosis of known genetic parameters within the MHC
AU3528400A (en) Apoptosis related genes
AUPQ262599A0 (en) Gene expression
AU6277600A (en) Novel chimeric genes
AU2376200A (en) Insulin-synthesis genes
AU5815500A (en) Genes controlling diseases
AU6596600A (en) Novel frizzled family genes 584
AU2001259595A1 (en) Haplotypes of the crybb1 gene
AU1624601A (en) Human wnt gene
AU2001257020A1 (en) Haplotypes of the hsd3b1 gene
AU4552700A (en) Gene therapy
AU2001290603A1 (en) Haplotypes of the or11a1 gene
AU7621700A (en) Novel members of the iap gene family
AU2002227177A1 (en) Haplotypes of the scya21 gene
AU2001249650A1 (en) Haplotypes of the chrnb3 gene
AU2001273117A1 (en) Haplotypes of the appbp1 gene
AU2001274995A1 (en) Haplotypes of the rlbp1 gene
AU2002245073A1 (en) Haplotypes of the f2rli gene
AU2001286644A1 (en) Haplotypes of the gng7 gene
AU2002213185A1 (en) Haplotypes of the chrm5 gene
AU2001292815A1 (en) Haplotypes of the scya8 gene
AU2001288868A1 (en) Haplotypes of the gpr68 gene
AU2002239511A1 (en) Haplotypes of the gsr gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase